Clinical Trial: Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

Share this article:
Clinical Trial: Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

Sponsor and Collaborators

Memorial Sloan-Kettering Cancer Center

Contact
Contact: Nancy Lee, MD
212-639-3341

Contact: Heiko Schoder, MD
212-639-2079

Principal Investigator

Nancy Lee, MD Memorial Sloan-Kettering Cancer Center

ClinicalTrials.gov Identifier
NCT00606294
Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Head and Neck Cancer Clinical Trials

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs